{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:45:11Z","timestamp":1791945911483,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010819","name":"Bureau of Education of Guangzhou Municipality","doi-asserted-by":"publisher","award":["2024312089"],"award-info":[{"award-number":["2024312089"]}],"id":[{"id":"10.13039\/501100010819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08764-0","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:34:27Z","timestamp":1787754867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MSC-derived exosomes co-delivering anti-miR-221 and gemcitabine for inhibiting the proliferation of pancreatic cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Bingqing","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiexie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhebing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5822-0653","authenticated-orcid":false,"given":"Xuewei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"10","key":"8764_CR1","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1007\/s12094-024-03484-7","volume":"26","author":"Abdul Qahar Khan Yasinzai","year":"2024","unstructured":"Abdul Qahar Khan Yasinzai. Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study. Clin Transl Oncol. 2024;26(10):2618\u201328.","journal-title":"Clin Transl Oncol"},{"key":"8764_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.annonc.2020.11.013","volume":"32","author":"R Casolino","year":"2021","unstructured":"Casolino R, et al. Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. Ann Oncol. 2021;32:183\u201396.","journal-title":"Ann Oncol"},{"issue":"9","key":"8764_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12032-024-02450-1","volume":"41","author":"AA Nourhan","year":"2024","unstructured":"Nourhan AA, Madawi, et al. Targeted gene therapy for cancer: the impact of microRNA. multipotentiality Med Oncol. 2024;41(9):214.","journal-title":"multipotentiality Med Oncol"},{"issue":"11","key":"8764_CR4","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.3390\/cancers13112680","volume":"13","author":"S El Reda","year":"2021","unstructured":"El Reda S, et al. MicroRNA therapeutics in cancer: current advances and challenges. Cancers. 2021;13(11):2680.","journal-title":"Cancers"},{"key":"8764_CR5","doi-asserted-by":"crossref","unstructured":"Liang L, et al. Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression. Genes Dis. 2023;11(5):101203.","DOI":"10.1016\/j.gendis.2023.101203"},{"issue":"3","key":"8764_CR6","first-page":"163","volume":"41","author":"TY Ellie","year":"2024","unstructured":"Ellie TY, Mok, et al. miRNAs Pancreat cancer progression metastasis Clin Exp Metastasis. 2024;41(3):163\u201386.","journal-title":"miRNAs Pancreat cancer progression metastasis Clin Exp Metastasis"},{"key":"8764_CR7","doi-asserted-by":"crossref","unstructured":"Xu C, et al. circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through PTEN mediated PI3K\/AKT signaling pathway. Biol Direct. 2023;18(1):14.","DOI":"10.1186\/s13062-023-00368-8"},{"key":"8764_CR8","unstructured":"Xuejiao, Wu et al. MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value.Cancer Cell Int. 2020;10:20443."},{"issue":"31","key":"8764_CR9","doi-asserted-by":"publisher","first-page":"21365","DOI":"10.1039\/D3RA02969G","volume":"13","author":"Liquan","year":"2023","unstructured":"Liquan, Hong, et al. Nanoparticle-based drug delivery systems targeting cancer cell surfaces. RSC Adv. 2023;13(31):21365\u201382.","journal-title":"RSC Adv"},{"key":"8764_CR10","doi-asserted-by":"crossref","unstructured":"Cheng X, et al. Advances in nanomaterial-based targeted drug delivery systems. Front Bioeng Biotechnol. 2023;13:111177151.","DOI":"10.3389\/fbioe.2023.1177151"},{"key":"8764_CR11","first-page":"9751079","volume":"8","author":"Huizhi","year":"2021","unstructured":"Huizhi, Chen, et al. Exosomes, a New Star for Targeted Delivery.Front Cell Dev Biol. Oct. 2021;8:9751079.","journal-title":"Oct"},{"issue":"1","key":"8764_CR12","first-page":"107","volume":"44","author":"Po-Fu","year":"2025","unstructured":"Po-Fu, Yueh, et al. Innovative dual-gene delivery platform using miR-124 and PD-1 via umbilical cord mesenchymal stem cells and exosome for glioblastoma therapy. J Exp. Clin Cancer Res. 2025;44(1):107.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"8764_CR13","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1245\/s10434-019-07269-z","volume":"26","author":"S Nakamura","year":"2019","unstructured":"Nakamura S, et al. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2019;26(7):2104\u201311.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"8764_CR14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2217\/nnm-2016-0035","volume":"11","author":"Reza","year":"2016","unstructured":"Reza, Shahbazi, et al. Oligonucleotide-based theranostic nanoparticles in cancer therapy. Nanomed (Lond). 2016;11(10):1287\u2013308.","journal-title":"Nanomed (Lond)"},{"key":"8764_CR15","doi-asserted-by":"crossref","unstructured":"Park JK, et al. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of Gemcitabine in pancreatic adenocarcinoma. Pancreas. 2009;38(7):e190\u20139.","DOI":"10.1097\/MPA.0b013e3181ba82e1"},{"key":"8764_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13148-015-0166-1","volume":"7","author":"SA Dhayat","year":"2015","unstructured":"Dhayat SA, et al. MicroRNA-100 and microRNA\u201021 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II. Clin Epigenetics. 2015;7:132.","journal-title":"Clin Epigenetics"},{"key":"8764_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/1535-7163.MCT-08-0592","volume":"8","author":"T Moriyama","year":"2009","unstructured":"Moriyama T, et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther. 2009;8:1067\u201374.","journal-title":"Mol Cancer Ther"},{"issue":"10242","key":"8764_CR18","first-page":"2008","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, et al. Pancreat cancer Lancet. 2020;395(10242):2008\u201320.","journal-title":"Pancreat cancer Lancet"},{"issue":"8","key":"8764_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein AN, et al. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020;17(8):487\u2013505.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"8764_CR20","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/ijms25073645","volume":"25","author":"Xuan","year":"2024","unstructured":"Xuan, Wang, et al. Enhanced Therapeutic Potential of Hybrid Exosomes Loaded with Paclitaxel for Cancer Therapy. Int J Mol Sci. 2024;25(7):3645.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8764_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41419-025-07443-0","volume":"16","author":"Yuzhu","year":"2025","unstructured":"Yuzhu, Shi, et al. Engineered mesenchymal stem\/stromal cells against cancer. Cell Death Dis. 2025;16(1):113.","journal-title":"Cell Death Dis"},{"key":"8764_CR22","doi-asserted-by":"crossref","unstructured":"Yudie Y, et al. Low intensity ultrasound-facilitated exosome delivery promotes hippocampal neurogenesis in Alzheimer\u2019s disease. Brain Stimul. 2026;19(1):103015.","DOI":"10.1016\/j.brs.2025.103015"},{"key":"8764_CR23","doi-asserted-by":"publisher","first-page":"115110","DOI":"10.1016\/j.addr.2023.115110","volume":"Nov","author":"S Li","year":"2023","unstructured":"Li S, et al. Lipid bilayer-based biological nanoplatforms for sonodynamic cancer therapy. Adv Drug Deliv Rev. 2023;Nov:202:115110.","journal-title":"Adv Drug Deliv Rev"},{"key":"8764_CR24","doi-asserted-by":"publisher","first-page":"111914","DOI":"10.1016\/j.biopha.2021.111914","volume":"141","author":"Mohadeseh","year":"2021","unstructured":"Mohadeseh, Fathi, et al. Emerging roles of miRNAs in the development of pancreatic cancer. Biomed Pharmacother. 2021;141:111914.","journal-title":"Biomed Pharmacother"},{"key":"8764_CR25","doi-asserted-by":"crossref","unstructured":"Xu C, et al. CircACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through PTEN mediated PI3K\/AKT signaling pathway. Biol Direct.2023;18(1):14.","DOI":"10.1186\/s13062-023-00368-8"},{"issue":"7","key":"8764_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"Carneiro","year":"2020","unstructured":"Carneiro, et al. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395\u2013417.","journal-title":"Nat Rev Clin Oncol"},{"issue":"Pt 2","key":"8764_CR27","doi-asserted-by":"publisher","first-page":"124832","DOI":"10.1016\/j.ijbiomac.2023.124832","volume":"242","author":"Asif Ahmad Bhat","year":"2023","unstructured":"Asif Ahmad Bhat. The pyroptotic role of Caspase-3\/GSDME signalling pathway among various cancer. Rev Int J Biol Macromol. 2023;242(Pt 2):124832.","journal-title":"Rev Int J Biol Macromol"},{"issue":"4","key":"8764_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard C, et al. Tumor angiogenesis and vascular normalization. Angiogenesis. 2017;20(4):409\u201326.","journal-title":"Angiogenesis"},{"issue":"1","key":"8764_CR29","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1038\/s41467-022-33991-6","volume":"13","author":"DK Kim","year":"2022","unstructured":"Kim DK, et al. PD-L1-directed PlGF\/VEGF blockade synergizes with chemotherapy by targeting CD141\u2009+\u2009cancer-associated fibroblasts in pancreatic cancer. Nat Commun. 2022;13(1):6292.","journal-title":"Nat Commun"},{"issue":"3","key":"8764_CR30","first-page":"655","volume":"12","author":"MS Kim","year":"2016","unstructured":"Kim MS, et al. Development of exosome-encapsulated paclitaxel to overcome MDR. cancer cells Nanomed. 2016;12(3):655\u201364.","journal-title":"cancer cells Nanomed"},{"key":"8764_CR31","doi-asserted-by":"publisher","first-page":"21648","DOI":"10.1038\/srep21648","volume":"6","author":"R Gradiz","year":"2016","unstructured":"Gradiz R, Silva HC, Carvalho L, Botelho MF, Mota-Pinto A. MIA PaCa-2 and PANC-1 \u2013 pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors. Sci Rep. 2016;6:21648.","journal-title":"Sci Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08764-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:03:08Z","timestamp":1791943388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08764-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8764"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08764-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Humane care guided by the guidelines of the National Institutes of Health was provided to all animals. All mice were raised under specific pathogen-free conditions, following the procedures approved by the Animal Use and Ethics Committee of the Second Affiliated Hospital of Guangzhou Medical University.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agree to the publication of the article.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1298"}}